Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$1.90 Mil
% of Total Estimate Gain
36.80%

TWIN CAPITAL MANAGEMENT INC's Regeneron Pharmaceuticals Inc Holding Summary

As of 2025-03-31, TWIN CAPITAL MANAGEMENT INC held - shares of Regeneron Pharmaceuticals Inc(REGN), totaling N/A. This investment constitutes 0% of their stock portfolio, and TWIN CAPITAL MANAGEMENT INC now holds 0% of the outstanding Regeneron Pharmaceuticals Inc(REGN) stock.

The initial trade took place in 2015Q2. And since then TWIN CAPITAL MANAGEMENT INC has made 10 purchases of REGN, at an average price of $408.96, for a total of 12,619.00 shares. In addition, there have been 18 sales at an average price of $559.45 for 12,619.00 shares. Based on historical transaction data and REGN's current price of $547.36, TWIN CAPITAL MANAGEMENT INC's estimated gain on his REGN holdings is $1.90 Mil, reflecting a 36.80% gain to date.

TWIN CAPITAL MANAGEMENT INC REGN ($547.36) Holding Chart

TWIN CAPITAL MANAGEMENT INC REGN ($547.36) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1